Zoccali C - Search Results

1

Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients.

Locatelli F, Andrulli S, Memoli B, Maffei C, Del Vecchio L, Aterini S, De Simone W, Mandalari A, Brunori G, Amato M, Cianciaruso B, Zoccali C. Locatelli F, et al. Among authors: zoccali c. Nephrol Dial Transplant. 2006 Apr;21(4):991-8. doi: 10.1093/ndt/gfk011. Epub 2005 Dec 29. Nephrol Dial Transplant. 2006. PMID: 16384825

2

Hypertension in end-stage renal disease: target values, methods of measurement and drug therapy.

Zoccali C. Zoccali C. J Nephrol. 2002 Mar-Apr;15(2):199-201. J Nephrol. 2002. PMID: 12018640 Review. No abstract available.

3

Oxidative stress in end-stage renal disease: an emerging threat to patient outcome.

Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Locatelli F, et al. Among authors: zoccali c. Nephrol Dial Transplant. 2003 Jul;18(7):1272-80. doi: 10.1093/ndt/gfg074. Nephrol Dial Transplant. 2003. PMID: 12808161 Review.

4

The importance of diabetic nephropathy in current nephrological practice.

Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Locatelli F, et al. Among authors: zoccali c. Nephrol Dial Transplant. 2003 Sep;18(9):1716-25. doi: 10.1093/ndt/gfg288. Nephrol Dial Transplant. 2003. PMID: 12937216 Review.

5

Convection versus diffusion in dialysis: an Italian prospective multicentre study.

Bolasco P, Altieri P, Andrulli S, Basile C, Di Filippo S, Feriani M, Pedrini L, Santoro A, Zoccali C, Sau G, Locatelli F. Bolasco P, et al. Among authors: zoccali c. Nephrol Dial Transplant. 2003 Aug;18 Suppl 7:vii50-4; discussion vii59-62. doi: 10.1093/ndt/gfg1080. Nephrol Dial Transplant. 2003. PMID: 12953031 Clinical Trial.

6

Achievement of target blood pressure levels in chronic kidney disease: a salty question?

De Nicola L, Minutolo R, Bellizzi V, Zoccali C, Cianciaruso B, Andreucci VE, Fuiano G, Conte G; investigators of the TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group. De Nicola L, et al. Among authors: zoccali c. Am J Kidney Dis. 2004 May;43(5):782-95. doi: 10.1053/j.ajkd.2004.01.009. Am J Kidney Dis. 2004. PMID: 15112168 Review.

7

Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease.

Zoccali C, Mallamaci F, Tripepi G. Zoccali C, et al. Nephrol Dial Transplant. 2004 Aug;19 Suppl 5:V67-72. doi: 10.1093/ndt/gfh1059. Nephrol Dial Transplant. 2004. PMID: 15284363 Review.

8

[Microhematuria. Prevalence, test validity and clinical usefulness].

Mandalari A, Zoccali C. Mandalari A, et al. Among authors: zoccali c. G Ital Nefrol. 2004 Mar-Apr;21(2):165-70. G Ital Nefrol. 2004. PMID: 15351951 Italian.

9

Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides.

Mallamaci F, Cutrupi S, Pizzini P, Tripepi G, Zoccali C. Mallamaci F, et al. Among authors: zoccali c. J Nephrol. 2005 Nov-Dec;18(6):727-32. J Nephrol. 2005. PMID: 16358231

10

Fibrinogen and calcium x phosphate product are predictors of cardiovascular events in the CAPD population.

Enia G, Panuccio V, Mallamaci F, Tripepi G, Mandalari A, Zoccali C. Enia G, et al. Among authors: zoccali c. J Nephrol. 2005 Nov-Dec;18(6):764-9. J Nephrol. 2005. PMID: 16358236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,002 results

Search Page